Evidence map›Paper›PMID 35926008›Full record

ArticleCirculation research2022

Calcineurin Controls Hypothalamic NMDA Receptor Activity and Sympathetic Outflow.

Kaushik P Patel, Hong Zheng

Open access · bronzeAbstract readEditorialComment
In one paragraph

Article in Circulation research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Kaushik P PatelDepartment of Integrative and Cellular Physiology, University of Nebraska Medical Center, Omaha (K.P.P.).ORCID 0000-0002-4500-0819
Hong ZhengBasic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion (H.Z.).ORCID 0000-0002-1660-3573
University of Nebraska Medical Center · USUniversity of South Dakota · US

Funding

The Role of Excitatory Input into the PVN on Increased Sympathetic Drive in HeartP01HL062222 · NHLBI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SCHULTZ, HAROLD D · 1999 to 2019
$32.2M
Novel Target Mechanism (Renal Denervation) to Reduce Sodium Retention in Chronic Heart FailureR01DK114663 · NIDDK · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PATEL, KAUSHIK P, ZHENG, HONG · 2017 to 2021
$2.1M
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failureR01DK129311 · NIDDK · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PATEL, KAUSHIK P, ZHENG, HONG · 2021 to 2024
$2.0M
Role of HIF1-alpha and Renal afferents in Activation of the PVN in Heart FailureR56HL124104 · NHLBI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PATEL, KAUSHIK P · 2014 to 2014
$354k
NHLBI NIH HHS P01 HL062222NHLBI NIH HHS R01 HL124104NHLBI NIH HHS R56 HL124104NIDDK NIH HHS R01 DK114663NIDDK NIH HHS R01 DK129311
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CalcineurinReceptors, N-Methyl-D-AspartateBlood PressureHypothalamusParaventricular Hypothalamic NucleusSympathetic Nervous SystemCalcineurinReceptors, N-Methyl-D-Aspartate

Identifiers

PMID35926008
PMCPMC9351814
OpenAlexW4289792279

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.